Infant heart drug under the microscope: new study aims to learn how digoxin works in tiny bodies

NCT ID NCT06613477

First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 27 times

Summary

This study looks at how the heart medication digoxin is processed in infants born with a single ventricle heart defect. Researchers will collect blood samples and review medical records from about 20 babies under 6 months old. The study does not change the baby's treatment plan or medications. The goal is to better understand how the drug works in these infants to improve future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFANT, PREMATURE, DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27701, United States

    Contact Email: •••••@•••••

  • Medical University of South Carolina

    NOT_YET_RECRUITING

    Charleston, South Carolina, 29425, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.